Apr 27, 2022 | Insights
U.S. Senators returned to Washington, D.C. on April 25, and resumed consideration of a proposed COVID-19 Supplemental Appropriations Bill. The bill would provide $10 billion in funding for additional vaccines, testing, and therapeutics. However, the Senate would pay...
